Olympus Announces First Results of Its AI-Based Pathology Diagnostic Tool for Gastric Cancer The AI achieved 100% sensitivity and 50% or more specificity

November 16, 2021

The results of Olympus’ ongoing joint research program1 to create an AI-based pathology diagnostic tool with the potential to streamline pathologists’ workloads were announced at the Japan Society of Digital Pathology Study annual meeting. The diagnostic tool achieved 100% sensitivity2 and 50% or more specificity3 for all gastric biopsy pathology specimens analyzed.

News Release DetailsPDF

Information posted on this site is current and accurate only at the time of their original publication date, and may now be outdated or inaccurate.